![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.95 | 1.90 | 2.00 | 1.95 | 1.95 | 1.95 | 268,538 | 08:00:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.37 | 15.12M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/10/2023 14:43 | Not surprised by this price action at all. Many towels being thrown in and with good reason.The company is badly managed (apart from the CFO who comes across well). The next few years aren't expected to be any easier than the last few. The end of shareholder dilution is completely unknown.There is value in this company but that value is so unknown and unquantifiable (accurately) that I suspect majority of holders (like myself) hold it because they have lost so much, it's currently just a very very expensive lottery ticket. | ![]() reviewwworld | |
11/10/2023 14:42 | Another screenshot taken. | ![]() the imperialist | |
11/10/2023 14:30 | Less than a penny to go till The all time low yet again ! Next RNS He's added to his substantial option award at no increase in share price But has to remained employed and taking the huge salary Verging on criminality | ![]() amaretto1 | |
11/10/2023 14:24 | One things for sure They will both have the same share price soon ! | ![]() amaretto1 | |
11/10/2023 13:23 | Prove me wrong ! I'll wager 10k to any childrens charity That by Xmas APTA will far far outperform STX ! Anyone ?? | ![]() amaretto1 | |
11/10/2023 13:12 | Back to 6p we're it came from my even go lower with dilution. Watching | ![]() goforgold1 | |
11/10/2023 13:08 | "APTA is by many in the know the only standout investment in this space"CHUCKLING HAHAHA Always liked Ameretto but something changed a few months back and turned her into a pessimist | zeus19 | |
11/10/2023 13:07 | I'm not saying it's easy for Norgine and totally recognise that bringing an expensive branded drug in against years old cheap generics was always a hard sell.But they've clearly not established sufficiently well that 30% odd fail on orals so there must be a place for Ferracru (before or against IV).No France, Italy, Spain, Netherlands, Australia, Scotland etc for such a simple useful drug is a nightmare for Norgine & Shield | ![]() skcots48 | |
11/10/2023 12:55 | APTA is by many in the know the only standout investment in this space at present that could seriously out perform by a considerable amount ! AGL a possibility Scancell may achieve goals DES another The rest are useing AIM has cash machines for life styles And have done this for years | ![]() amaretto1 | |
11/10/2023 12:47 | Yet another thread ruined. I'm also invested in APTA and it's a real shame that these posters are ruining both the APTA and STX bulletin boards. | ![]() parob | |
11/10/2023 12:44 | What is it a inverted rocket ? It's halved in less than a month u tool | ![]() amaretto1 | |
11/10/2023 12:38 | Let's hope so, more fuel for the rockets. | ![]() the imperialist | |
11/10/2023 12:26 | Infact I'd go has far to say The Shorters from a year ago Are back here ! | ![]() amaretto1 | |
11/10/2023 12:15 | Norgine presumably used same criteria in Germany uk which was accepted so not sure if it was solely cost. The head to head dstudy with IV was a debacle the study showed equal efficacy at week12 and beyond they set the wrong goals unfortunately then miss read the data causing Norgine a headache. But looking at the open prescribing data they are clearly gaining momentum in the uk in the last 6/9 months | ![]() best1467 | |
11/10/2023 12:11 | For context, Ammo has just been turned upon by the genuine holders of APTA, and told to stop his incessant multi-ID ramping. So he's feeling a little unloved...bless him. | ![]() the imperialist | |
11/10/2023 12:03 | The last fund raise Actually broke the camel's back And basically attracted another one of many sellers yet again The last 2 years have been a disaster for STX holders I don't often agree with Wally no mates on the other thread But in this case i do !! | ![]() amaretto1 | |
11/10/2023 11:07 | Skcots48: you could also argue that Norgine are succeeding despite themselves, and now scrambling to catch up with a runaway hit wherever it gets going - hence all the England regional hires to manage the explosion in demand from doctors. | ![]() jimbren | |
11/10/2023 10:22 | unfortunately there seems to be ample stock around with a big background seller depressing the price and using every opportunity to sell since the fall from 12 The big sell order looks like it's being managed and worked painful espcially as we were so close to finally leaving these trash levels behind at what point does Shield start looking attractive to a bidder? AOP are in prime position themselves if they feel as if they've had enough?! any outside would be suitor would need AOP's blessing but could potentially pick up shield "on the cusp greatness" for peanuts Heaven forbid (no pun intended) and it would be a real kick in the nuts for shareholders as company are within 12-15 months of the promised land defintely wouldn't rule it out if the share price continues to sink | ![]() tripletop1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions